Yingnan Wang

机构：Ningbo Medical Center Lihuili Hospital · ORCID：0000-0002-7547-277X

发表论文 71 篇 · 总被引 648 次 · h-index 11

代表论文

• Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial (2024 · Nature Medicine · 被引 174)
• Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancer (2021 · Gastroenterology report · 被引 28)
• PARP1-catalyzed PARylation of YY1 mediates endoplasmic reticulum stress in granulosa cells to determine primordial follicle activation (2023 · Cell Death and Disease · 被引 21)
• Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review (2022 · Frontiers in Oncology · 被引 19)
• Gastric metastasis from breast cancer: five cases and a single-institutional review (2024 · Journal of International Medical Research · 被引 16)
• Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc (2022 · Oncogene · 被引 16)